logo
ProjectCompleted

Alkaloid A.D.

One of 961 projects Taiyo tracks in North Macedonia.

Source: International Finance Corporation (IFC)

Environmental Review Summary (ERS)Project Name:				FYR of Macedonia – Alkaloid A.D.Region:				Central and Southern Europe (CSEG1)Sector:					G-IB - Pharmaceuticals (including vitamins)Project No:				0091081.	Alkaloid A.D. is a Skopje-based joint stock company manufacturing pharmaceutical, chemical, cosmetic, coating and food products.  The company was founded in 1936 for the production of narcoti
Status
Closed
Sector
Waste Processing and Treatment, Biomass, Chemical (Industrial), Water Supply and Storage, Hospital, Government, Manufacturing (Industrial)
Location
Macedonia
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Alkaloid A.D.

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Alkaloid A.D.” is an infrastructure initiative in the Waste Processing and Treatment sector, located in North Macedonia. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

completed

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Environmental Review Summary (ERS)Project Name: FYR of Macedonia – Alkaloid A.D.Region: Central and Southern Europe (CSEG1)Sector: G-IB - Pharmaceuticals (including vitamins)Project No: 0091081. Alkaloid A.D. is a Skopje-based joint stock company manufacturing pharmaceutical, chemical, cosmetic, coating and food products. The company was founded in 1936 for the production of narcotics using the morphine extracted from locally grown poppies. Alkaloid, now one of the most successful in the country and leader in the domestic pharmaceutical sector, is currently organized in four profit centers: (i) pharmaceutical products; (ii) fine chemicals and cosmetics; (iii) herbs; and (iv) coatings. Main pharmaceutical products include capsules, pills, tablets, ampoules in different dosage forms, ointments, creams, jellies, syrups and solutions. Most of these products are primarily used as analgesics, antibiotics for wide applications, anti-diabetics and tranquilizers. Alkaloid consists of four existing facilities all located in and around the capital city. The company employs a total of 1,758 workers.2. IFC and EBRD are considering providing parallel convertible loans to Alkaloid. The proceeds of the loans will be used for (i) the completion of a new pharmaceutical production facility to comply with Good Manufacturing Practice standards, and (ii) the upgrade the Company’s related pharmaceutical production facilities. The total cost is estimated at DM63.2 million equivalent, and the project is expected to be completed by end of 2001. 3. This is a category B project according to IFC’s environmental review procedure because specific impacts may result which can be avoided or mitigated by adhering to generally recognized performance standards, guidelines or design criteria. The review of the project consisted of appraising technical and environmental information submitted by the project sponsor, and the technical appraisal completed by IFC’s environment staff. With respect to the new pharmaceutical operation, the following potential environmental, health and safety impacts of the project were analyzed:· liquid effluent;· air emissions;· solid waste disposal and disposal of pharmaceutical products;· adverse drug effects and product recalls;· fire prevention and emergency response;· workplace health and safety, particularly air quality.4. An independent consultant was contracted by EBRD to undertake an environmental audit of the existing manufacturing component of the company, as required by IFC. The audit was designed to identify any environmental liability issues, and any environmental and worker health and safety risks associated with past and current operation of the plant, particularly issues related to soil and ground water contamination. The consultants also reviewed relevant environmental information including the Environmental Impact Assessment undertaken by the company in relation to the new developments and identified and assess the conformity with any Macedonian requirements for public participation.5. The information provided by Alkaloid about how each of the potential impacts (listed in paragraph 3 above) will be addressed in the development of the proposed project is summarized in the following paragraphs. The company commits to implement the project in accordance to Macedonian and EU regulations as well as IFC requirements. Liquid effluents. Wastewater includes sewage and effluent produced by washing equipment and floors. Wastewater will be discharged in the city sewer with characteristics compliant with local regulations.Air emissions. These include small quantities (4.7 Kg/h in total) of filler particles, colors and flavors, preservatives, traces of active substances, and solvents (alcohol, water). The project includes a central dust control system to reduce particulate emissions to acceptable levels.Solid waste disposal and disposal of pharmaceutical products. Most of the wastes will be disposed of in the municipal landfill facility. A small amount of solids, which are not suitable for municipal disposal, will be destroyed in accordance to Macedonian regulations and international good practice. Occupational health and safety. Handling of hazardous materials (biohazards, solvents, etc.) and staff protection against noise and other occupational hazards will be undertaken according to international good practice. Air quality inside the plant will be controlled with a 7-stage system, which ensures 99.99% efficiency in the removal of breathable particulate matter. Detection instruments for organic solvents will also be installed. The company undertakes periodic medical check-ups to monitor the health of the staff and provides regular training in personal protection and emergency response. This practice will continue with the implementation of the project.Fire prevention and emergency response. Fire prevention and emergency response measures compatible with IFC Health and Safety Guidelines have been duly considered in the project.6. IFC’s conclusion is that Alkaloid’s existing facilities and proposed project will meet IFC’s environmental, health and safety policies and guidelines, World Bank Group pollution prevention and abatement guidelines and requirements of the government of FYR of Macedonia and the European Union. This conclusion is based on IFC’s initial review of information provided by the company regarding potential environmental impacts and proposed mitigation measures of this project, the independent audit report completed in April 1999 and the corresponding Environmental Action Plan. Although Alkaloid’s current operations are not fully compliant with IFC requirements, the company has formally committed to follow the recommendations of the independent audit report and to implement prevention, mitigation and control measures as per the corresponding Environmental Action Plan within the timeframe established therein.7. IFC will monitor ongoing compliance with IFC’s environmental, health and safety policies and guidelines and World Bank Group pollution prevention and abatement guidelines during the lifetime of the project by evaluating reports submitted annually to IFC by Alkaloid and by conducting periodic supervision. Both the annual monitoring reports and supervision missions will make reference to all Alkaloid’s facilities in Skopje.

Original sector

FA - Pharmaceuticals and Medicine

Location

Country

Macedonia

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Waste Processing and Treatment, Biomass, Chemical (Industrial), Water Supply and Storage, Hospital, Government, Manufacturing (Industrial)

Article published date

2025-08-08

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project